Growth Metrics

Zevra Therapeutics (ZVRA) Change in Acquisitions & Divestments (2018 - 2025)

Zevra Therapeutics' Change in Acquisitions & Divestments history spans 6 years, with the latest figure at $87.5 million for Q4 2025.

  • For Q4 2025, Change in Acquisitions & Divestments rose 43216.83% year-over-year to $87.5 million; the TTM value through Dec 2025 reached $178.5 million, up 614.0%, while the annual FY2025 figure was $178.5 million, 614.0% up from the prior year.
  • Change in Acquisitions & Divestments reached $87.5 million in Q4 2025 per ZVRA's latest filing, up from $60.5 million in the prior quarter.
  • In the past five years, Change in Acquisitions & Divestments ranged from a high of $87.5 million in Q4 2025 to a low of $202000.0 in Q4 2024.
  • Average Change in Acquisitions & Divestments over 4 years is $22.9 million, with a median of $13.6 million recorded in 2024.
  • Peak YoY movement for Change in Acquisitions & Divestments: crashed 98.71% in 2024, then surged 43216.83% in 2025.
  • A 4-year view of Change in Acquisitions & Divestments shows it stood at $300000.0 in 2022, then surged by 5108.33% to $15.6 million in 2023, then plummeted by 98.71% to $202000.0 in 2024, then soared by 43216.83% to $87.5 million in 2025.
  • Per Business Quant, the three most recent readings for ZVRA's Change in Acquisitions & Divestments are $87.5 million (Q4 2025), $60.5 million (Q3 2025), and $12.5 million (Q2 2025).